|
Match
|
Document |
Document Title |
|
|
US20130122297 |
MOLECULAR GAUGE BLOCKS FOR BUILDING ON THE NANOSCALE
Disclosed herein is a way to produce a series of discrete sized slender, rigid oligoparaxylene molecules ranging from 1-5 nm in length. Molecules, based on 1-7, 9-11 paraxylene rings, have been... |
|
|
US20130041016 |
Compositions and Methods for Preventing and Treating Cancer via Modulating UBE1L, ISG215 and/or UBP43
Compositions and methods of using compositions that induce UBE1L or a ubiquitin-like protein ISG15, or inhibit a deconjugase UBP43 to degrade oncogenic proteins and enhance apoptosis of cancer... |
|
|
US20110269991 |
PURE CARBOXYLIC ACID FILTRATION
The present invention relates to a process for production of pure terephthalic acid comprising: a) removing a mother liquor from a terephthalic acid through a filter with a gas, wherein the gas... |
|
|
US20130078198 |
NOVEL USE
This invention relates to the use of sodium dodecylbenzene sulphonate (SDDBS) for helping to prevent or remove surface deposited stains from natural teeth and dental prostheses and oral care... |
|
|
US20140051772 |
CLEANING AGENT COMPOSITION
The problem of the present invention is provision of a cleansing composition providing good amount and good quality of lather. Using a particular alkenoic acid or a salt thereof, the... |
|
|
US20140239231 |
Carbon Dioxide Conversion To Fuels And Chemicals
An environmentally beneficial process for the production of fuels and chemicals employs carbon dioxide from a natural source or from an artificial chemical source that would otherwise be... |
|
|
US20120020881 |
Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes
This invention relates to novel compounds suitable for labeling by positron emitting isotopes, such as 18F, 11C, 13N and 15O, through appropriate labeling reagents, such as 18F reagents and... |
|
|
US20120302788 |
METHODS FOR PRODUCTION OF ARGININE AT LOW PRESSURE
A method of producing arginine bicarbonate is provided including reacting an arginine slurry with a source of carbon dioxide gas under elevated temperature and low pressure to form a solution of... |
|
|
US20130303761 |
COMPOUNDS AS MODULATORS OF A MUTANT CFTR PROTEIN AND THEIR USE FOR TREATING DISEASES ASSOCIATED WITH CFTR PROTEIN MALFUNCTION
The present invention relates to novel protein modulators capable of altering function of the mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction. The... |
|
|
US20130122141 |
FLAVOR CONTAINING L-GLUTAMIC ACID AND METHOD THEREOF
Disclosed herein is a method for producing a flavoring containing L-glutamic acid derived from natural foods by adjusting the content of ammonia remaining in a final fermentation broth after... |
|
|
US20110105608 |
MODULATORS OF NUCLEAR RECEPTOR CO-REGULATORY PROTEIN BINDING
Disclosed are novel compounds and compositions for inhibition of androgen and estrogen receptor signaling, methods for inhibiting androgen signaling, methods for inhibiting estrogen signaling,... |
|
|
US20140316158 |
METHOD OF OBTAINING ACETATE FROM LIGNOCELLULOSE SPECIFICATION IDENTIFICATION
A method of obtaining an aqueous solution of an alkali acetate from lignocellulose, wherein lignocellulose is treated with a first aqueous extraction solution having a pH value in the range of 12... |
|
|
US20150073131 |
METHOD FOR PRODUCING BIOBASED CHEMICALS FROM PLANT LIGNIN
The present invention is directed generally to a method of production of value-added, biobased chemicals from lignin sources, including waste lignin. A method of producing biobased aromatic... |
|
|
US20140378735 |
METHOD OF DETOXIFYING ASBESTOS CONTAINED IN WASTE SLATE AND DETOXIFIED ASBESTOS OBTAINED THROUGH THE SAME
Disclosed is a method of detoxifying asbestos of waste slate. The method includes concentrating the asbestos by introducing hydrochloric acid aqueous solution into waste slate powder to dissolve... |
|
|
US20110059924 |
Chemoprevention of Colorectal Cancer by Mesalamine/Sulfasalazine
A method for preventing or treating colorectal cancer in a patient possessing human tropomyocin isoform TC22 is presented. Also presented is a method for evaluating TC22 expression reduction... |
|
|
US20110201707 |
ISOCYANATE TRIMERISATION CATALYST SYSTEM, A PRECURSOR FORMULATION, A PROCESS FOR TRIMERISING ISOCYANATES, RIGID POLYISOCYANURATE/POLYURETHANE FOAMS MADE THEREFROM, AND A PROCESS FOR MAKING SUCH FOAMS
The instant invention provides an isocyanate trimerisation catalyst system, a precursor formulation, a process for trimerising isocyanates, rigid foams made therefrom, and a process for making... |
|
|
US20150246876 |
HIGH-PURITY SODIUM P-STYRENESULFONATE WITH EXCELLENT HUE, METHOD FOR PRODUCING THE SAME, POLY (SODIUM P-STYRENESULFONATE) WITH EXCELLENT HUE USING THE SAME, AND DISPERSANT AND SYNTHETIC STARCH FOR CLOTHING FINISHING USING THE POLY ( SODIUM P-STYRENESULFONATE)
Provided are high purity sodium p-styrenesulfonate with an excellent hue which is useful as a reactive emulsifier or dispersant for producing a polymer emulsion, or synthetic starch for clothing... |
|
|
US20140206901 |
RECOMBINANT MICROORGANISMS AND METHODS OF USE THEREOF
The invention relates to methods for the production of chemical compounds, particularly but not exclusively ethanol, by microbial fermentation. Also described are genetically modified... |
|
|
US20140117280 |
OXYGEN ABSORBER
An oxygen absorber is provided that contains at least one of compounds each having a particular structure, and the oxygen absorber exhibits an oxygen absorbing capability without a metal... |
|
|
US20150247281 |
REDUCED MEDICAL WET PACKS, POST STEAM STERILIZATION
The present disclosure describes a surfactant treatment for a polyolefinic nonwoven fabric used to wrap items to be sterilized. The surfactant treatment consists essentially of carbon, hydrogen... |
|
|
US20110252507 |
TRANSGENIC PLANTS USED AS A BIOREACTOR SYSTEM
The present invention relates generally to the use of plants as bioreactors for the production of molecules having useful properties such as inter alia polymers, metabolites, proteins,... |
|
|
US20110165098 |
METHODS TO PREVENT CYTOTOXICITY USING N-ACETYL-CYSTEINE
Compositions and methods to inhibit adverse physiological effects caused by resin-based and resin-containing materials are disclosed. More specifically, the use of N-acetyl-cysteine (NAC) to... |
|
|
US20120157392 |
Epilepsy treatment employing ketogenic compounds which arrest apoptosis
Method of treating a patient suffering from apoptosis of tissue by administering to the patient a therapeutically effective amount of one or more ketogenic compounds such that a physiological... |
|
|
US20150057325 |
COMPOUNDS CAPABLE OF MODULATING/PRESERVING ENDOTHELIAL INTEGRITY FOR USE IN PREVENTION OR TREATMENT OF ACUTE TRAUMATIC COAGULOPATHY AND RESUSCITATED CARDIAC ARREST
The present invention relates to novel uses of compounds that protect the endothelium, particularly prostacyclin and variants and derivatives thereof in the treatment or prevention of acute... |
|
|
US20130261177 |
COMPOUNDS CAPABLE OF MODULATING/PRESERVING ENDOTHELIAL INTEGRITY FOR USE IN PREVENTION OR TREATMENT OF ACUTE TRAUMATIC COAGULOPATHY AND RESUSCITATED CARDIAC ARREST
The present invention relates to novel uses of compounds that protect the endothelium, particularly prostacyclin and variants and derivatives thereof in the treatment or prevention of acute... |
|
|
US20120195984 |
DIAGNOSIS AND TREATMENT OF THE PRODROMAL SCHIZOPHRENIC STATE
Described herein are compounds (including medical foods, pharmaceutical compositions, methods of compounding them), methods and systems for the diagnosis and/or treatment of prodromal... |
|
|
US20140242606 |
PROBE FOR iFRET AND USE THEREOF
The present invention relates to a probe for iFRET and use thereof. Specifically, the present invention relates to a novel probe for iFRET, a method for preparing the probe for iFRET, a method for... |
|
|
US20150073176 |
LINEAR ALKYLBENZENES FROM NATURAL OILS AND METHODS OF PRODUCING
A linear alkylbenzene product and a linear alkylbenzene sulfonate product from a natural oil are provided. The linear alkylbenzene product comprises alkylbenzenes having the formula C6H5CnH2n+1... |
|
|
US20110176998 |
IMAGING AND THERAPY OF VIRUS-ASSOCIATED TUMORS
The present invention features compositions and methods for detecting, selecting a treatment method for, monitoring, and treating a neoplasia associated with a viral infection. |
|
|
US20120264902 |
Methods, Systems and Compositions for Increased Microorganism Tolerance to and Production of 3-Hydroxypropionic Acid (3-HP)
The present invention relates to methods, systems and compositions, including genetically modified microorganisms, adapted to exhibit increased tolerance to 3-hydroxypropionic acid (3-HP),... |
|
|
US20120003156 |
METHODS FOR TREATING NEOPLASIA BY INHIBITING LACTATE DEHYDROGENASE AND/OR NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE
The invention provides compositions for the diagnosis or treatment of neoplasias, including lymphomas, leukemias, brain cancers (e. glioblastomas, medulloblastomas), breast cancer, colon cancer,... |
|
|
US20140256817 |
AMPHIPATHIC AND OTHER DOUBLE-SIDED ALPHA-HELIX MIMETICS BASED ON A 1,2-DIPHENYLACETYLENE SCAFFOLD
Small-molecule scaffolds based on 1,2-diphenylacetylene that accurately replicate the spatial and angular projections of several side chains on both faces of an α-helix, specifically the i and i+7... |
|
|
US20130143967 |
Organosulfur compounds for the prevention and treatment of neurodegenerative diseases
S-allylmercapto-N-acetylcysteine and related compounds are disclosed which can be administered in order to provide protection from the formation of aldehyde-protein adducts, protein carbonylation,... |
|
|
US20110269689 |
HIGH PENETRATION COMPOSITIONS AND THEIR APPLICATIONS
High penetration compositions (HPC) of a parent compound, which are capable of crossing biological barriers with high penetration efficiency. The HPCs are capable of being converted to parent... |
|
|
US20110189094 |
BIOLOGICAL METHOD FOR IN VIVO TRACKING OF MOLECULES AFFECTING CELLULAR MIGRATION
Cellular migration is a normal part of the normal development of the human being and, in certain pathologies, its alteration damages physiological performance, so that it is necessary to learn... |
|
|
US20120088782 |
LPA RECEPTOR ANTAGONIST
A compound of the general formula (I): (wherein the symbols are as defined in the description), or a non-toxic salt thereof. This compound engages in LPA receptor bonding and antagonism and hence... |
|
|
US20120142958 |
CHEMICAL RECYCLING OF PLA BY HYDROLYSIS
A process for recycling a polymer blend necessarily containing PLA, comprising grinding, compacting, dissolving in a solvent of PLA, removing the undissolved contamining polymers, alcoholysis... |
|
|
US20120178966 |
METHODS FOR PRODUCTION OF L-METHIONINE AND RELATED PRODUCTS
A method comprising: (a) enzymatically processing an O-acetylhomoserine (OAHS) fermentation liquor to produce L-methionine and an acetate source; (b) separating at least a portion of said... |
|
|
US20110064712 |
Dietary Supplement Compositions and Methods of Making and Using the Same
Dietary supplement compositions are disclosed. Methods of making and using dietary supplement compositions are also disclosed. |
|
|
US20150250752 |
COMPOSITION CONTAINING LYSINE AS A NUTRITIONAL SUPPLEMENT OR TREATMENT IN THE CASE OF HERPES
The invention relates to a composition comprising, related to a daily dose of the composition, as its active ingredients L-lysine ranging from ≧750 mg to −9 g, suitable as a nutritional supplement... |
|
|
US20150073170 |
KINETIC RESOLUTION
Whilst methodologies for the Kinetic Resolution of alcohols are well established, no analogous direct methods exist for the highly selective, direct catalytic Kinetic Resolution of thiols (i.e.,... |
|
|
US20120277437 |
KINETIC RESOLUTION
Whilst methodologies for the Kinetic Resolution of alcohols are well established, no analogous direct methods exist for the highly selective, direct catalytic Kinetic Resolution of thiols (i.e.,... |
|
|
US20120220502 |
COMPOSITIONS COMPRISING ALKYLALKOXYSULFONATES FOR THE PRODUCTION OF HIGH TEMPERATURE STABLE FOAMS
The present invention is directed to the use of alkylalkoxysulfonates for the production of foams, which are stable at high temperatures, e.g. up to about 250° C. Furthermore, the invention... |
|
|
US20110319493 |
HISTONE DEACETYLASES, AND USES RELATED THERETO
The present invention concerns the discovery that proteins encoded by a family of genes, termed here HDx-related genes, which are involved in the control of chromatin structure and, thus in... |
|
|
US20110313045 |
HISTONE DEACETYLASES, AND USES RELATED THERETO
The present invention concerns the discovery that proteins encoded by a family of genes, termed here HDx-related genes, which are involved in the control of chromatin structure and, thus in... |
|
|
US20110218154 |
HISTONE DEACETYLASES, AND USES RELATED THERETO
The present invention concerns the discovery that proteins encoded by a family of genes, termed here HDx-related genes, which are involved in the control of chromatin structure and, thus in... |
|
|
US20110251216 |
COMPOSITIONS AND METHODS FOR INHIBITING EZH2
The present invention relates to therapeutic targets for cancer. In particular, the present invention relates to small molecules and nucleic acids that target EZH2 expression in cancer (e.g.,... |
|
|
US20130061752 |
Tetratopic Phenyl Compounds, Related Metal-Organic Framework Materials and Post-Assembly Elaboration
Disclosed are tetratopic carboxylic acid phenyl for use in metal-organic framework compounds. These compounds are useful in catalysis, gas storage, sensing, biological imaging, drug delivery and... |
|
|
US20110280815 |
COMPOSITION FOR INHIBITING MELANIN PRODUCTION AND APPLICATION THEREOF
The present invention provides a composition for inhibiting melanin production to promote skin whitening, which is characterized by containing compounds represented by formula (I): wherein R1, R2... |
|
|
US20150018316 |
Compounds, Methods, and Treatments for Abnormal Signaling Pathways for Prenatal and Postnatal Development
The present invention relates to prevention of congenital deformations. The invention further relates to cancer inhibition and prevention. The invention further relates to methods and compositions... |